Work

Impact-AL: A phase 2 clinical trial of teclistamab and daratumumab in previously untreated AL amyloidosis

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-2197

Authors: Rajshekhar Chakraborty, Anita D'Souza, Omar Siddiqi, Shikun Wang, Margaret Doyle, Sanjay Vara, Benjamin Schroeder, Jordan Schecter, Catherine Higgins, Renee Smith, Vaishali Sanchorawala, Suzanne Lentzsch

Institutions: Columbia University Irving Medical Center, Columbia University, Medical College of Wisconsin, Boston Medical Center

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417012004

Cites:

Cited by:

Related to: